Yuan G.

Yuan G. has a diverse work experience spanning various companies and roles. They are currently employed as the Head of Analytical Development at ADC Therapeutics since May 2022. Prior to this, they held the position of Senior Director at Innoforce Pharmaceuticals from June 2021 to May 2022. From December 2019 to May 2021, they served as a Senior Director at Canton Biologics. Before that, they worked as a Sr. Scientist at Boehringer Ingelhgeim Fremont, Inc. from January 2018 to December 2019. Yuan G. also held the role of Principal Scientist I at Novo Nordisk Research Centre China from November 2015 to January 2018. They worked as an Investigator II at China Novartis Institutes for BioMedical Research (CNIBR) from November 2014 to November 2015. Prior to their industry experience, Yuan G. had research positions at the National Center for Toxicological Research, US Food and Drug Administration as a Staff Fellow from August 2011 to October 2014, and as a Postdoctoral Research Fellow from April 2008 to August 2011. They began their research career as a Research/Teaching Assistant at the University of California, Riverside from September 2003 to April 2008, where they focused on LC-MS and MALDI MS for protein modification studies. Their earliest research experience was as a Research/Teaching Assistant at Fudan University from September 1999 to June 2002.

Yuan G. completed a PhD in Bioanalytical Chemistry at the University of California, Riverside from 2003 to 2008. Prior to that, Yuan obtained a BS and MS degree in Chemistry with a focus on Bioinorganic/Protein Chemistry from Fudan University between 1995 and 2002. No information is provided regarding any education at Georgetown University or Life Academy.